U.S. Intravenous Immunoglobulin Market

U.S. Intravenous Immunoglobulin Market Size, Share, Growth Analysis, By Application(Primary Immunodeficiency, Chronic Inflammatory, Demyelinating Polyradiculoneuropathy, Congenital AIDS), By Distribution Channels(Hospital Pharmacy, Specialty Pharmacy, others), By Region - Industry Forecast 2024-2031

Report ID: SQMIC35G2279 | Region: Country | Published Date: March, 2024
Pages: 219 | Tables: 70 | Figures: 77

U.S. Intravenous Immunoglobulin Market Competitive Landscape

The top companies in the IVIG market in the US are concentrating on growth tactics such as product releases, R&D, mergers & acquisitions, and advancements in the IVIG products already on the market.

U.S. Intravenous Immunoglobulin Market Top Player’s Company Profiles

  • Nestlé (Switzerland)
  • Unilever (Netherlands/UK)
  • General Mills (United States)
  • The Kraft Heinz Company (United States)
  • Mars, Incorporated (United States)
  • Blue Bell Creameries (United States)
  • Wells Enterprises, Inc. (United States)
  • Dreyer's Grand Ice Cream Holdings, Inc. (United States)
  • Rich Products Corporation (United States)
  • Ben & Jerry's Homemade Holdings Inc. (United States)
  • Häagen-Dazs (United States)
  • Turkey Hill Dairy (United States)
  • Tillamook County Creamery Association (United States)
  • Dean Foods (United States)
  • Breyers (United States)
  • TCBY (United States)
  • Velvet Ice Cream (United States)
  • Good Humor (United States)
  • Jeni's Splendid Ice Creams (United States)
  • Perry's Ice Cream (United States)
  • Talenti Gelato (United States)
  • Coolhaus (United States)

U.S. Intravenous Immunoglobulin Market

$3,500
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

U.S. Intravenous Immunoglobulin Market size was valued at USD 5.78 billion in 2022 and is poised to grow from USD 6.24 billion in 2023 to USD 11.46 billion by 2031, at a CAGR of 7.90% during the forecast period (2024-2031).

The top companies in the IVIG market in the US are concentrating on growth tactics such as product releases, R&D, mergers & acquisitions, and advancements in the IVIG products already on the market. 'Nestlé (Switzerland)', 'Unilever (Netherlands/UK)', 'General Mills (United States)', 'The Kraft Heinz Company (United States)', 'Mars, Incorporated (United States)', 'Blue Bell Creameries (United States)', 'Wells Enterprises, Inc. (United States)', 'Dreyer's Grand Ice Cream Holdings, Inc. (United States)', 'Rich Products Corporation (United States)', 'Ben & Jerry's Homemade Holdings Inc. (United States)', 'Häagen-Dazs (United States)', 'Turkey Hill Dairy (United States)', 'Tillamook County Creamery Association (United States)', 'Dean Foods (United States)', 'Breyers (United States)', 'TCBY (United States)', 'Velvet Ice Cream (United States)', 'Good Humor (United States)', 'Jeni's Splendid Ice Creams (United States)', 'Perry's Ice Cream (United States)', 'Talenti Gelato (United States)', 'Coolhaus (United States)'

Frozen dessert manufacturers continue to innovate and introduce new flavors, textures, and formats to cater to evolving consumer preferences. This includes offering healthier options, such as low-fat, low-sugar, and dairy-free alternatives, to meet the growing demand for healthier treats.

Indulgent and Decadent Treats : Despite the growing emphasis on healthier options, indulgence remains a strong driver in the frozen dessert market. Consumers still seek rich, creamy, and indulgent frozen treats like premium ice creams, gelatos, and decadent frozen novelties. Manufacturers continue to offer luxurious Flavors and textures to satisfy these cravings.

The Northeast region, comprising states such as New York, New Jersey, Massachusetts, Pennsylvania, and Connecticut, has a significant presence in the IVIG market. This region is home to renowned medical institutions, research facilities, and academic centers, which contribute to the availability and adoption of IVIG treatments. The dense population and advanced healthcare infrastructure in cities like New York City and Boston further enhance the prominence of the IVIG market in the Northeast.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Intravenous Immunoglobulin Market
Buy Now GET FREE SAMPLE
Immunoglobulin Market
Buy Now GET FREE SAMPLE
Immunoassay Market
Buy Now GET FREE SAMPLE
Immunohematology Market
Buy Now GET FREE SAMPLE
Immunodiagnostics Market
Buy Now GET FREE SAMPLE
Monoclonal Antibody Therapy Market
Buy Now GET FREE SAMPLE
Immunology Market
Buy Now GET FREE SAMPLE
Monoclonal Antibodies Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

U.S. Intravenous Immunoglobulin Market

Report ID: SQMIC35G2279

$3,500
BUY NOW GET FREE SAMPLE